Bhakta Avinash, Tafen Marcel, Glotzer Owen, Ata Ashar, Chismark A David, Valerian Brian T, Stain Steven C, Lee Edward C
Department of Surgery, Albany Medical College, Albany, New York.
Dis Colon Rectum. 2016 Apr;59(4):316-22. doi: 10.1097/DCR.0000000000000550.
Surgical site infection is a key hospital-level patient safety indicator. All risk factors for surgical site infection are not always taken into account and adjusted for.
This study aimed to measure the impact of IBD in comparison with diverticulitis and colorectal cancer on the national rates of surgical site infection.
The American College of Surgeons National Surgical Quality Improvement Project database was queried for all patients undergoing elective colectomy for colon cancer, diverticulitis, and IBD from 2008 through 2012.
The association between surgical site infection and IBD patients was assessed. Patient demographics, rates of surgical site infection, wound class, return to operating room, and various patient characteristics were analyzed. Logistic regression was performed to determine the association with surgical site infection.
The query yielded 71,845 patients undergoing elective colectomy. Of these patients, 42,132 had colon cancer, 22,143 had diverticulitis, and 7570 had IBD. The rate of surgical site infection was 12.0% for colon cancer, 12.8% for diverticulitis, and 18.0% for IBD. Return to operating room within 30 days was 7.3% for IBD patients, 4.4% for patients with diverticulitis, and 4.9% for patients with colorectal cancer. Return to operating room within 30 days had the highest correlation to surgical site infection in both univariate and multivariable analysis. Other associative factors for surgical site infection common to both analyses included diabetes mellitus, smoking, open procedures, and obesity.
This study was limited by the data collection errors inherent to large databases, exclusion of emergent operations, and the inability to identify patients taking immunosuppressive agents.
Patients with IBD undergoing elective colectomy have significantly increased rates of surgical site infection, specifically deep and organ/space infections. Given this information, risk adjustment models for surgical site infection may need to include IBD in their calculation.
手术部位感染是医院层面患者安全的关键指标。并非所有手术部位感染的风险因素都会被考虑及调整。
本研究旨在衡量炎症性肠病(IBD)与憩室炎和结直肠癌相比,对全国手术部位感染率的影响。
查询美国外科医师学会国家外科质量改进项目数据库中2008年至2012年因结肠癌、憩室炎和IBD接受择期结肠切除术的所有患者。
评估手术部位感染与IBD患者之间的关联。分析患者人口统计学资料、手术部位感染率、伤口分类、返回手术室情况及各种患者特征。进行逻辑回归以确定与手术部位感染的关联。
查询得到71845例接受择期结肠切除术的患者。其中,42132例患有结肠癌,22143例患有憩室炎,7570例患有IBD。结肠癌患者的手术部位感染率为12.0%,憩室炎患者为12.8%,IBD患者为18.0%。IBD患者30天内返回手术室的比例为7.3%,憩室炎患者为4.4%,结直肠癌患者为4.9%。在单变量和多变量分析中,30天内返回手术室与手术部位感染的相关性最高。两种分析中手术部位感染的其他相关因素包括糖尿病、吸烟、开放手术和肥胖。
本研究受到大型数据库固有的数据收集错误、排除急诊手术以及无法识别服用免疫抑制剂患者的限制。
接受择期结肠切除术的IBD患者手术部位感染率显著增加,尤其是深部和器官/腔隙感染。鉴于此信息,手术部位感染的风险调整模型在计算中可能需要纳入IBD。